Financials

  • Market Capitalization 517.63 M
  • Employee 149
  • Founded 2018
  • CEO N/A
  • Website www.kyvernatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RCYMHR1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2885
CABA
Cabaletta Bio, Inc. - Common Stock
3.12 USD-7.69%+0.97%+16.85%+112.24%528.98 M USD
2892
ENTX
Entera Bio Ltd. - Ordinary Shares
3.03 USD-1.62%-7.62%+4.12%+56.19%524.62 M USD
2937
EDIT
Editas Medicine, Inc. - Common Stock
3.16 USD-4.24%+0.64%+22.48%+25.40%485.31 M USD
2943
EVMN
Evommune, Inc. Common Stock
13.22 USD-1.56%-3.36%+18.67%-23.67%479.78 M USD